CompanyRARENasdaqNovato, CA

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical develops therapies for rare and ultra-rare genetic diseases.

SEC EDGAR ClinicalTrials.gov

10-KSep 28Latest SEC filing

Aug 11Latest story

August 2026

Ultragenyx reports Q2 2026 results, cites two PDUFA dates and Angelman readout ahead

Aug 4Quarterly updateapazunersen rebisufligene etisparvovec